Piramal Enterprises’ arm completes 20% stake sale to Carlyle Group

07 Oct 2020 Evaluate

Piramal Enterprises’ subsidiary -- Piramal Pharma has completed sale of 20 per cent stake for Rs 3,523.40 crore to US-based global investment firm Carlyle Group Inc. Piramal Pharma has received Rs 3,523.40 crore from CA Alchemy Investments, an affiliated entity of CAP V Mauritius, an investment fund managed and advised by affiliated entities of The Carlyle Group Inc.

The transaction values the Pharma Business at an enterprise value of $2,775 million (over Rs 20,300 crore) with an upside component of up to $360 million (over Rs 2,630 crore) depending on the company's FY21.

Piramal Enterprises is one of India’s large diversified companies, with a presence in Pharmaceuticals, Healthcare Information Management and Financial Services.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers
Company Name CMP
Bajaj Finance 927.85
Shriram Finance 1003.45
Aditya Birla Capital 347.85
Chola Invest & Fin. 1642.60
Tata Capital 352.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×